Re: Catheter-directed Thrombolytic Therapy for Limb Ischemia: Current Status and Controversies [1]

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 5, 2004, Pages 517-

  Semba, Charles P ^a   Tam, Iris ^a   Blaney, Martha ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFIMEPRASE; ALTEPLASE; HUMAN DERIVED UROKINASE; PROUROKINASE; RECOMBINANT UROKINASE; RETEPLASE; STREPTOKINASE; TENECTEPLASE; UNCLASSIFIED DRUG; UROKINASE;

BLOOD VESSEL CATHETERIZATION; FIBRINOLYTIC THERAPY; FOOD AND DRUG ADMINISTRATION; LETTER; LIMB ISCHEMIA; MEDICAL RECORD; MEDICATION ERROR; NOMENCLATURE; PRIORITY JOURNAL;

EID: 2342514810     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000124945.58200.90     Document Type: Letter

References (4)

1. Razavi MK, Lee DS, Hofmann LV. Catheter-directed thrombolytic therapy for limb ischemia: current status and controversies. J Vasc Interv Radiol 2003; 14:1491-1501.
2. Razavi MK, Lee DS, Hofmann LV. Catheter-directed thrombolytic therapy for limb ischemia: current status and controversies (corrected and republished). J Vasc Interv Radiol 2004; 15:13-23.
3. USP's Hospital Medication Error Report Supports Key Patient Safety Goals. Press release, December 8, 2003. Available at www.usp.org.
4. United States Adopted Names Council, Chicago, IL. Available at www.ama-assn.org.